Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eloxx Pharmaceuticals, Inc. - Common Stock (NQ:ELOX)

18.00 -1.07 (-5.61%)
Streaming Delayed Price Updated: 3:54 PM EDT, Aug 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 28,581
Open 19.23
Bid (Size) 17.83 (200)
Ask (Size) 18.48 (100)
Prev. Close 19.07
Today's Range 17.17 - 19.23
52wk Range 8.200 - 19.96
Shares Outstanding 2,752,774
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Eloxx Pharmaceuticals Provides ELX-02 and ZKN-013 Program Updates
From Eloxx Pharmaceuticals
Via GlobeNewswire
News headline image
Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to license ZKN-013 for rare dermatological diseases
From Eloxx Pharmaceuticals
Via GlobeNewswire

Performance

YTD
+63.5%
+63.5%
1 Month
+59.9%
+59.9%
3 Month
+63.5%
+63.5%
6 Month
+63.5%
+63.5%
1 Year
+63.5%
+63.5%

More News

Read More
News headline image
Off the Beaten Path: 3 Delisted Stocks for The Speculative Investor ↗
Via InvestorPlace
News headline image
Eloxx Pharmaceuticals Reports Third Quarter 2023 Financial and Operating Results and Provides Business Update
From Eloxx Pharmaceuticals
Via GlobeNewswire
Eloxx Pharmaceuticals Inc. (NASDAQ: ELOX) Near the Top of Equities by Percentage Gain on 8/30
Via Investor Brand Network
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
Via Benzinga
News headline image
Eloxx Pharmaceuticals Reports Additional Confirmation that All Nonsense Mutation Alport Syndrome Patients Treated with ELX-02 in Phase 2 Study had Improvement in Kidney Morphology and Clinical Benefit of Reduction or Stabilization of Proteinuria
From Eloxx Pharmaceuticals
Via GlobeNewswire
News headline image
Eloxx Pharmaceuticals Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
From Eloxx Pharmaceuticals
Via GlobeNewswire
News headline image
Eloxx Pharmaceuticals Reports Independent Confirmation of Positive Biopsy Results in All Patients Treated with ELX-02 in Phase 2 Clinical Study for Alport Syndrome
From Eloxx Pharmaceuticals
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Via Benzinga
News headline image
Eloxx Pharmaceuticals Provides Program Updates on ELX-02 and ZKN-013
From Eloxx Pharmaceuticals
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Via Benzinga
News headline image
Why 22nd Century Group Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Via Benzinga
News headline image
Eloxx Pharmaceuticals Reports Second Quarter 2023 Financial and Operating Results and Provides Business Update
From Eloxx Pharmaceuticals
Via GlobeNewswire
News headline image
Why US Steel Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Eloxx Pharmaceuticals Reports Drug Response in All Patients Treated with ELX-02 in Phase 2 Clinical Study for Alport Syndrome
From Eloxx Pharmaceuticals
Via GlobeNewswire
News headline image
Eloxx Pharmaceuticals Granted Extension by Nasdaq to Regain Compliance with the Market Value of Listed Securities Continued Listing Requirement
From Eloxx Pharmaceuticals
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Via Benzinga
News headline image
Why Progressive Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Via Benzinga
News headline image
Why Senmiao Technology Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Via Benzinga
News headline image
This Small Cap Stock Surged Over 100%
Via MarketBeat
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Via Benzinga
News headline image
Why ImmuCell Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
Via InvestorPlace

Frequently Asked Questions

Is Eloxx Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Eloxx Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Eloxx Pharmaceuticals, Inc. - Common Stock trade on?
Eloxx Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Eloxx Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Eloxx Pharmaceuticals, Inc. - Common Stock is ELOX on the Nasdaq Stock Market
What is the current price of Eloxx Pharmaceuticals, Inc. - Common Stock?
The current price of Eloxx Pharmaceuticals, Inc. - Common Stock is 18.00
When was Eloxx Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Eloxx Pharmaceuticals, Inc. - Common Stock was at 08/14/26 03:54 PM ET
What is the market capitalization of Eloxx Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Eloxx Pharmaceuticals, Inc. - Common Stock is 49.55M
How many shares of Eloxx Pharmaceuticals, Inc. - Common Stock are outstanding?
Eloxx Pharmaceuticals, Inc. - Common Stock has 50M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.